| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 4.99e-09 | 11 | 41 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 5.28e-07 | 32 | 41 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.62e-06 | 42 | 41 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.44e-04 | 130 | 41 | 4 | GO:0005200 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 3.67e-07 | 31 | 40 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 6.08e-07 | 35 | 40 | 4 | GO:0099188 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 4.86e-07 | 32 | 42 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 4.86e-07 | 32 | 42 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.98e-06 | 45 | 42 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | actin filament | 1.07e-05 | 146 | 42 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.76e-05 | 94 | 42 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.59e-05 | 104 | 42 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | chromosome passenger complex | 5.88e-05 | 6 | 42 | 2 | GO:0032133 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 6.72e-05 | 109 | 42 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | spindle pole centrosome | 6.59e-04 | 19 | 42 | 2 | GO:0031616 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 1.92e-03 | 899 | 42 | 7 | GO:0099513 | |
| GeneOntologyCellularComponent | spindle midzone | 2.93e-03 | 40 | 42 | 2 | GO:0051233 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 5.72e-03 | 576 | 42 | 5 | GO:0015629 | |
| Domain | ANK | POTEB3 POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 1.37e-15 | 251 | 38 | 13 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 1.52e-15 | 253 | 38 | 13 | PS50088 |
| Domain | ANK_REP_REGION | POTEB3 POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 1.60e-15 | 254 | 38 | 13 | PS50297 |
| Domain | Ankyrin_rpt | POTEB3 POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 2.40e-15 | 262 | 38 | 13 | IPR002110 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG | 6.11e-14 | 254 | 38 | 12 | IPR020683 |
| Domain | Ank_2 | POTEB3 POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEF POTEC POTEG | 3.34e-13 | 215 | 38 | 11 | PF12796 |
| Domain | Ank | POTEE MIB2 POTEI POTEJ POTEM POTEH POTEB POTEF POTEC POTEG POTED | 6.35e-13 | 228 | 38 | 11 | PF00023 |
| Domain | - | POTEB3 POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEF POTEC POTEG | 1.59e-12 | 248 | 38 | 11 | 1.25.40.20 |
| Domain | ZnF_C2HC | 1.52e-11 | 55 | 38 | 7 | SM00343 | |
| Domain | Znf_CCHC | 1.52e-11 | 55 | 38 | 7 | IPR001878 | |
| Domain | Actin_CS | 2.60e-08 | 16 | 38 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 3.40e-08 | 17 | 38 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.37e-08 | 18 | 38 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.52e-08 | 19 | 38 | 4 | PS01132 | |
| Domain | Actin | 4.41e-07 | 31 | 38 | 4 | IPR004000 | |
| Domain | Actin | 4.41e-07 | 31 | 38 | 4 | PF00022 | |
| Domain | ACTIN | 4.41e-07 | 31 | 38 | 4 | SM00268 | |
| Domain | Aur | 1.21e-05 | 3 | 38 | 2 | IPR030616 | |
| Domain | ZF_ZZ_2 | 6.04e-04 | 18 | 38 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.04e-04 | 18 | 38 | 2 | PS01357 | |
| Domain | ZZ | 6.04e-04 | 18 | 38 | 2 | PF00569 | |
| Domain | Znf_ZZ | 6.74e-04 | 19 | 38 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 6.74e-04 | 19 | 38 | 2 | SM00291 | |
| Domain | Peptidase_M12B_N | 2.85e-03 | 39 | 38 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.85e-03 | 39 | 38 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.99e-03 | 40 | 38 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 2.99e-03 | 40 | 38 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.99e-03 | 40 | 38 | 2 | PS50214 | |
| Domain | Reprolysin | 2.99e-03 | 40 | 38 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 2.99e-03 | 40 | 38 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 3.14e-03 | 41 | 38 | 2 | IPR001762 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 8.68e-03 | 69 | 38 | 2 | IPR020636 | |
| Domain | MetalloPept_cat_dom | 1.18e-02 | 81 | 38 | 2 | IPR024079 | |
| Domain | - | 1.18e-02 | 81 | 38 | 2 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 1.69e-02 | 98 | 38 | 2 | PS00142 | |
| Pubmed | FAM90A23 FAM90A2P FAM90A14 FAM90A17 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 FAM90A19 FAM90A22 | 3.00e-32 | 25 | 46 | 13 | 17684299 | |
| Pubmed | FAM90A23 FAM90A2P FAM90A14 FAM90A17 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 FAM90A19 FAM90A22 | 7.92e-27 | 23 | 46 | 11 | 18602769 | |
| Pubmed | 3.51e-20 | 8 | 46 | 7 | 12475935 | ||
| Pubmed | 3.81e-18 | 6 | 46 | 6 | 17171436 | ||
| Pubmed | 2.67e-17 | 7 | 46 | 6 | 15276201 | ||
| Pubmed | POTEB3 POTEE POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG | 1.97e-16 | 163 | 46 | 11 | 24316575 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A23 FAM90A14 FAM90A17 FAM90A1 FAM90A7 FAM90A9 FAM90A8 FAM90A10 FAM90A19 FAM90A22 FAM90A26 | 2.11e-16 | 164 | 46 | 11 | 22967998 |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.89e-14 | 15 | 46 | 6 | 16824795 | |
| Pubmed | 4.06e-13 | 9 | 46 | 5 | 16364570 | ||
| Pubmed | 2.68e-12 | 4 | 46 | 4 | 17342726 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 2.17e-09 | 3 | 46 | 3 | 17101985 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24603334 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28369513 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 33172986 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.71e-06 | 2 | 46 | 2 | 19669888 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22778418 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 33725274 | ||
| Pubmed | Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. | 1.71e-06 | 2 | 46 | 2 | 18447647 | |
| Pubmed | Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme. | 1.71e-06 | 2 | 46 | 2 | 34465813 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15499654 | ||
| Pubmed | Differential functions of the Aurora-B and Aurora-C kinases in mammalian spermatogenesis. | 1.71e-06 | 2 | 46 | 2 | 17192404 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24586209 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 24632603 | ||
| Pubmed | SAR156497, an exquisitely selective inhibitor of aurora kinases. | 5.13e-06 | 3 | 46 | 2 | 25369539 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 15917996 | ||
| Pubmed | Gene expression of Aurora kinases in prostate cancer and nodular hyperplasia tissues. | 5.13e-06 | 3 | 46 | 2 | 23075505 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 21123620 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 19774610 | ||
| Pubmed | Deregulation of Aurora kinase gene expression in human testicular germ cell tumours. | 5.13e-06 | 3 | 46 | 2 | 20629650 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 32452402 | ||
| Pubmed | Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis. | 5.13e-06 | 3 | 46 | 2 | 16386730 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 18353803 | ||
| Pubmed | Differential Selective Pressures Experienced by the Aurora Kinase Gene Family. | 5.13e-06 | 3 | 46 | 2 | 29283376 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 30077875 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 19649632 | ||
| Pubmed | Aurora kinase B inhibits aurora kinase A to control maternal mRNA translation in mouse oocytes. | 5.13e-06 | 3 | 46 | 2 | 34636397 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 31521144 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 12434334 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 28359584 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 30415701 | ||
| Pubmed | 8.14e-06 | 96 | 46 | 4 | 23580065 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 27332895 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 15316025 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 20663916 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 12584241 | ||
| Pubmed | Personalized copy number and segmental duplication maps using next-generation sequencing. | 1.71e-05 | 5 | 46 | 2 | 19718026 | |
| Pubmed | 4.59e-05 | 149 | 46 | 4 | 22664934 | ||
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 14602875 | ||
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 21613325 | ||
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 9.78e-05 | 67 | 46 | 3 | 34644545 | |
| Pubmed | 3.89e-04 | 22 | 46 | 2 | 25331947 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.55e-04 | 271 | 46 | 4 | 32433965 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 5.72e-04 | 288 | 46 | 4 | 31501420 | |
| Pubmed | Biochemical and computational analysis of LNX1 interacting proteins. | 8.28e-04 | 32 | 46 | 2 | 22087225 | |
| Interaction | POTEC interactions | 1.28e-11 | 13 | 34 | 5 | int:POTEC | |
| Interaction | POTEB3 interactions | 3.15e-09 | 35 | 34 | 5 | int:POTEB3 | |
| Interaction | POTEG interactions | 3.31e-09 | 12 | 34 | 4 | int:POTEG | |
| Interaction | POTED interactions | 1.75e-08 | 4 | 34 | 3 | int:POTED | |
| Interaction | ACTG2 interactions | 1.36e-06 | 49 | 34 | 4 | int:ACTG2 | |
| Interaction | POTEJ interactions | 1.73e-06 | 52 | 34 | 4 | int:POTEJ | |
| Interaction | POTEH interactions | 2.76e-06 | 2 | 34 | 2 | int:POTEH | |
| Interaction | FAM90A26 interactions | 2.76e-06 | 2 | 34 | 2 | int:FAM90A26 | |
| Interaction | POTEB2 interactions | 4.13e-05 | 6 | 34 | 2 | int:POTEB2 | |
| Interaction | ATPSCKMT interactions | 1.51e-04 | 11 | 34 | 2 | int:ATPSCKMT | |
| Interaction | CAP2 interactions | 1.87e-04 | 66 | 34 | 3 | int:CAP2 | |
| Interaction | DEFB107A interactions | 2.13e-04 | 13 | 34 | 2 | int:DEFB107A | |
| Cytoband | 8p23.1 | FAM90A23 FAM90A2P FAM90A14 FAM90A17 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 FAM90A19 FAM90A22 | 4.62e-20 | 154 | 46 | 12 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A23 FAM90A2P FAM90A14 FAM90A17 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 FAM90A19 FAM90A22 | 7.72e-18 | 234 | 46 | 12 | chr8p23 |
| Cytoband | 2q21.1 | 3.60e-07 | 58 | 46 | 4 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 1.65e-05 | 151 | 46 | 4 | chr2q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q11 | 1.36e-03 | 217 | 46 | 3 | chr15q11 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | POTEE POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 6.02e-31 | 13 | 27 | 11 | 685 |
| GeneFamily | Ankyrin repeat domain containing | POTEE MIB2 POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG POTED | 3.66e-16 | 242 | 27 | 12 | 403 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.24e-04 | 18 | 27 | 2 | 91 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | POTEB3 POTEE POTEI POTEJ POTEB2 POTEM POTEH POTEB POTEF POTEC POTEG | 1.57e-10 | 584 | 35 | 11 | MM1080 |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 1.43e-07 | 92 | 35 | 5 | MM503 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 1.84e-06 | 282 | 35 | 6 | MM3642 | |
| Coexpression | WEBER_METHYLATED_HCP_IN_SPERM_DN | 7.78e-06 | 29 | 35 | 3 | M1808 | |
| Coexpression | WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN | 2.59e-05 | 43 | 35 | 3 | M16646 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 5.35e-05 | 309 | 35 | 5 | MM1244 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 1.13e-04 | 188 | 35 | 4 | MM1071 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.38e-11 | 90 | 35 | 6 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.44e-09 | 63 | 35 | 5 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.89e-06 | 136 | 35 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.89e-06 | 136 | 35 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.18e-05 | 180 | 35 | 4 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.18e-05 | 180 | 35 | 4 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.68e-05 | 95 | 35 | 3 | 48ad5d89ee9a1941d1d3dbdbfb03893a390c0d64 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.86e-05 | 96 | 35 | 3 | 4cca2f5e754b82075740adaa0a147d16368be908 | |
| Drug | 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate | 1.91e-06 | 2 | 32 | 2 | ctd:C520647 | |
| Disease | brain cancer (implicated_via_orthology) | 1.26e-04 | 26 | 19 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Abnormality of refraction | 8.72e-03 | 673 | 19 | 3 | HP_0000539 | |
| Disease | lifestyle measurement | 9.88e-03 | 235 | 19 | 2 | EFO_0010724 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GWSVHTPSLRRKTMC | 186 | Q9UQB9 | |
| MWNKHRSSAGDCKCP | 381 | O75078 | |
| GHTARSTTCPMKCWK | 51 | A6NDY2 | |
| GHTARSTRCPMKCWK | 51 | A6NKC0 | |
| RSKMGKWCHHRFPCC | 21 | H3BUK9 | |
| TLRSKMGKWCCHCFP | 56 | H3BUK9 | |
| GHTARSTRCPMKCWK | 51 | A8MXZ1 | |
| TLRSKMGKWCRHCFP | 56 | A5A3E0 | |
| GHTARSTRCPMKCWK | 51 | Q86YD7 | |
| GHTARSTRCPMKCWK | 51 | A8MWA6 | |
| GHTARSTRCPMKCWK | 51 | P0C7W9 | |
| KWCMGKHEFRSNIPC | 801 | Q12986 | |
| CHWRKCPRERMQTSK | 21 | Q9HCC8 | |
| GHTARSTRCPMKCWK | 51 | P0DV74 | |
| KMKRRAVGIWHCGSC | 46 | P61513 | |
| GHTARSTRCPMKCWK | 51 | P0DV73 | |
| GHTARSTRCPMKCWK | 51 | P0DV76 | |
| RSKMGKWCHHRFPCC | 21 | A0JP26 | |
| TLRSKMGKWCHHCFP | 56 | Q6S8J3 | |
| GHTARSTRCPMKCWK | 51 | A6NJQ4 | |
| RTLCSSDRGCKKGWM | 126 | Q99572 | |
| WTPCSATCGKGTRMR | 1191 | Q9P2N4 | |
| GHTARSTRCPMKCWK | 51 | A6NIJ5 | |
| MKCWGKSGRCRTTCK | 21 | Q5J5C9 | |
| KNMKDLTCRWTPGAH | 146 | O75462 | |
| GHTARSTRCPMKCWK | 51 | A8MXJ8 | |
| SPLKGHKRFCMWRDC | 86 | Q9Y5R6 | |
| GHTARSTRCPMKCWK | 51 | P0C7X0 | |
| GPSHSKERKWKCSMC | 581 | Q9UKN5 | |
| KHGLRGMRWKCRVCL | 96 | Q96AX9 | |
| RSKMGKWFHHRFPCC | 21 | B2RU33 | |
| RSKMGKWCHHRFPCC | 21 | Q86YR6 | |
| WCKTASGHIKRPMNA | 41 | P35716 | |
| MRPSAKSLVCGKHWS | 1016 | Q8NDG6 | |
| RSKMGKWCHHRFPCC | 21 | A0A0A6YYL3 | |
| TLRSKMGKWCCHCFP | 56 | A0A0A6YYL3 | |
| GHTARSTRCPMKCWK | 51 | A8MX19 | |
| GHTARSTRCPMKCWK | 51 | A6NNJ1 | |
| GHTARSTRCPMKCWK | 51 | P0C7W8 | |
| GHMARSTRCPMKCWK | 51 | D6RGX4 | |
| TLRSKMGKWCCHCFP | 56 | P0CG39 | |
| TLRSKMGKWCCHCFP | 56 | P0CG38 | |
| GHTARSTRCPMKCWK | 51 | P0C7V4 | |
| HEGMKYWSCCRRKTS | 186 | Q9UHD1 | |
| WSVHAPSLRRKTMCG | 221 | Q96GD4 | |
| PQGCLGKWRSMRCKH | 21 | A8MWX3 | |
| GHTVRSTRCPMKCWK | 51 | Q658T7 | |
| PMHWCLNLKRSSACT | 66 | Q9UJT2 | |
| GSACSHWIRLKMKPD | 281 | O43149 | |
| HCKRPMSSRGWVCDR | 721 | Q96S15 | |
| TLRSKMGKWCRHCFP | 56 | Q6S5H5 | |
| TLRSKMGKWCCHCFP | 56 | Q6S545 | |
| TLRSKMGKWCRHCFP | 56 | A6NI47 | |
| GHTARSTRCPMKCWK | 51 | P0DV75 |